rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
BAL PHARMA LTD. - Outcome of Board Meeting
< Back
13 Apr 2016
Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 13, 2016, inter alia, has approved the allotment of 13,00,000 equity shares of Rs. 10/- each with a premium of Rs. 52/- per share of the Company on preferential basis to the investors who has exercised the conversion option on 13,00,000 warrants subscribed by them.&lt;BR&gt;&lt;BR&gt;With this allotment, the paid up equity share capital of the Company has enhanced to Rs. 14,17,23,720/- divided into 1,41,72,372 equity shares of Rs. 10 each.
View all announcements for BAL PHARMA LTD. Source: BSE India